iShares Biotechnology ETF Holdings
IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 8183.84m in AUM and 245 holdings. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.
Last Updated: 3 days, 18 hours ago
Last reported holdings - iShares Biotechnology ETF
| Ticker | Name | Est. Value |
|---|---|---|
|
GILD
|
GILEAD SCIENCES INC | $580.5 million |
|
VRTX
|
VERTEX PHARMACEUTICALS INC | $579.2 million |
|
AMGN
|
AMGEN INC | $564.6 million |
|
REGN
|
REGENERON PHARMACEUTICALS INC | $470.5 million |
|
ALNY
|
ALNYLAM PHARMACEUTICALS INC | $283.8 million |
|
ARGX
|
ARGENX SE ADR | $268.3 million |
|
BIIB
|
BIOGEN INC | $204.7 million |
|
NTRA
|
NATERA INC | $189.3 million |
|
RVMD
|
REVOLUTION MEDICINES INC | $186.1 million |
|
UTHR
|
UNITED THERAPEUTICS CORP | $176.0 million |
|
INSM
|
INSMED INC | $167.9 million |
|
ONC
|
BEONE MEDICINES AG | $154.8 million |
|
ILMN
|
ILLUMINA INC | $154.5 million |
|
INCY
|
INCYTE CORP | $138.2 million |
|
MRNA
|
MODERNA INC | $121.2 million |
|
NBIX
|
NEUROCRINE BIOSCIENCES INC | $110.6 million |
|
ROIV
|
ROIVANT SCIENCES LTD | $101.1 million |
|
GMAB
|
GENMAB SPONSORED ADR | $89.9 million |
|
EXEL
|
EXELIXIS INC | $89.7 million |
|
IONS
|
IONIS PHARMACEUTICALS INC | $87.6 million |
|
BBIO
|
BRIDGEBIO PHARMA INC | $80.5 million |
|
ASND
|
ASCENDIS PHARMA | $79.7 million |
|
MDGL
|
MADRIGAL PHARMACEUTICALS INC | $78.3 million |
|
AXSM
|
AXSOME THERAPEUTICS INC | $71.2 million |
|
MEDP
|
MEDPACE HOLDINGS INC | $70.2 million |
|
ARWR
|
ARROWHEAD PHARMACEUTICALS INC | $70.2 million |
|
BMRN
|
BIOMARIN PHARMACEUTICAL INC | $69.3 million |
|
CYTK
|
CYTOKINETICS INC | $67.5 million |
|
PRAX
|
PRAXIS PRECISION MEDICINES INC | $61.6 million |
|
HALO
|
HALOZYME THERAPEUTICS INC | $58.8 million |
|
KRYS
|
KRYSTAL BIOTECH INC | $54.6 million |
|
CRL
|
CHARLES RIVER LABORATORIES INTERNA | $54.4 million |
|
BNTX
|
BIONTECH SE ADR | $51.8 million |
|
TECH
|
BIO TECHNE CORP | $51.6 million |
|
PCVX
|
VAXCYTE INC | $50.2 million |
|
ALKS
|
ALKERMES | $44.3 million |
|
PTGX
|
PROTAGONIST THERAPEUTICS INC | $43.3 million |
|
RGEN
|
REPLIGEN CORP | $42.4 million |
|
ABVX
|
ABIVAX AMERICAN DEPOSITARY SHARES | $41.2 million |
|
PTCT
|
PTC THERAPEUTICS INC | $41.1 million |
|
RYTM
|
RHYTHM PHARMACEUTICALS INC | $40.7 million |
|
KYMR
|
KYMERA THERAPEUTICS INC | $40.1 million |
|
MIRM
|
MIRUM PHARMACEUTICALS INC | $37.0 million |
|
XENE
|
XENON PHARMACEUTICALS INC | $36.8 million |
|
NUVL
|
NUVALENT INC CLASS A | $35.3 million |
|
TEM
|
TEMPUS AI INC CLASS A | $34.7 million |
|
SRRK
|
SCHOLAR ROCK HOLDING CORP | $32.3 million |
|
BRKR
|
BRUKER CORP | $32.1 million |
|
SYRE
|
SPYRE THERAPEUTICS INC | $31.4 million |
|
CRSP
|
CRISPR THERAPEUTICS AG | $31.1 million |
|
COGT
|
COGENT BIOSCIENCES INC | $31.0 million |
|
TVTX
|
TRAVERE THERAPEUTICS INC | $28.1 million |
|
APGE
|
APOGEE THERAPEUTICS INC | $27.2 million |
|
LEGN
|
LEGEND BIOTECH ADR REP CORP | $26.1 million |
|
ACAD
|
ACADIA PHARMACEUTICALS INC | $25.2 million |
|
CRNX
|
CRINETICS PHARMACEUTICALS INC | $25.0 million |
|
VCYT
|
VERACYTE INC | $23.8 million |
|
CGON
|
CG ONCOLOGY INC | $23.6 million |
|
TWST
|
TWIST BIOSCIENCE CORP | $21.3 million |
|
CNTA
|
CENTESSA PHARMACEUTICALS AMERICAN | $20.4 million |
|
IBRX
|
IMMUNITYBIO INC | $19.7 million |
|
DNLI
|
DENALI THERAPEUTICS INC | $18.8 million |
|
TXG
|
10X GENOMICS INC CLASS A | $18.5 million |
|
TARS
|
TARSUS PHARMACEUTICALS INC | $18.0 million |
|
BEAM
|
BEAM THERAPEUTICS INC | $17.9 million |
|
NAMS
|
NEWAMSTERDAM PHARMA NV | $17.9 million |
|
EWTX
|
EDGEWISE THERAPEUTICS INC | $17.7 million |
|
ORKA
|
ORUKA THERAPEUTICS INC | $17.2 million |
|
IDYA
|
IDEAYA BIOSCIENCES INC | $17.2 million |
|
IMVT
|
IMMUNOVANT INC | $16.2 million |
|
GRAL
|
GRAIL INC | $15.7 million |
|
ARQT
|
ARCUTIS BIOTHERAPEUTICS INC | $15.7 million |
|
RARE
|
ULTRAGENYX PHARMACEUTICAL INC | $15.0 million |
|
BCRX
|
BIOCRYST PHARMACEUTICALS INC | $14.8 million |
|
ADMA
|
ADMA BIOLOGICS INC | $14.6 million |
|
DYN
|
DYNE THERAPEUTICS INC | $14.4 million |
|
KOD
|
KODIAK SCIENCES INC | $14.3 million |
|
ADPT
|
ADAPTIVE BIOTECHNOLOGIES CORP | $14.1 million |
|
ERAS
|
ERASCA INC | $14.0 million |
|
DFTX
|
DEFINIUM THERAPEUTICS INC | $13.9 million |
|
TNGX
|
TANGO THERAPEUTICS INC | $13.8 million |
|
VERA
|
VERA THERAPEUTICS INC CLASS A | $13.7 million |
|
RCUS
|
ARCUS BIOSCIENCES INC | $13.7 million |
|
IRON
|
DISC MEDICINE INC | $13.5 million |
|
GPCR
|
STRUCTURE THERAPEUTICS ADR INC | $13.5 million |
|
AUPH
|
AURINIA PHARMACEUTICALS INC | $13.4 million |
|
CAI
|
CARIS LIFE SCIENCES INC | $13.2 million |
|
NVCR
|
NOVOCURE LTD | $12.8 million |
|
ELVN
|
ENLIVEN THERAPEUTICS INC | $12.7 million |
|
ZYME
|
ZYMEWORKS INC | $12.7 million |
|
VCEL
|
VERICEL CORP | $12.7 million |
|
SMMT
|
SUMMIT THERAPEUTICS INC | $12.4 million |
|
SRPT
|
SAREPTA THERAPEUTICS INC | $12.1 million |
|
SNDX
|
SYNDAX PHARMACEUTICALS INC | $12.0 million |
|
RLAY
|
RELAY THERAPEUTICS INC | $11.6 million |
|
ANAB
|
ANAPTYSBIO INC | $11.3 million |
|
MLYS
|
MINERALYS THERAPEUTICS INC | $11.2 million |
|
ALMS
|
ALUMIS INC | $11.2 million |
|
ZLAB
|
ZAI LABORATORY ADR REPRESENTING LT | $11.1 million |
|
AGIO
|
AGIOS PHARMACEUTICALS INC | $10.9 million |
|
NRIX
|
NURIX THERAPEUTICS INC | $10.8 million |
|
NVAX
|
NOVAVAX INC | $10.1 million |
|
QURE
|
UNIQURE NV | $10.1 million |
|
NTLA
|
INTELLIA THERAPEUTICS INC | $9.8 million |
|
STOK
|
STOKE THERAPEUTICS INC | $9.8 million |
|
RXRX
|
RECURSION PHARMACEUTICALS INC CLAS | $9.6 million |
|
FTRE
|
FORTREA HOLDINGS INC | $9.4 million |
|
TYRA
|
TYRA BIOSCIENCES INC | $9.1 million |
|
IOVA
|
IOVANCE BIOTHERAPEUTICS INC | $8.9 million |
|
AMLX
|
AMYLYX PHARMACEUTICALS INC | $8.6 million |
|
TSHA
|
TAYSHA GENE THERAPIES INC | $8.5 million |
|
ATAI
|
ATAIBECKLEY INC | $8.4 million |
|
INBX
|
INHIBRX BIOSCIENCES INC | $8.2 million |
|
TRVI
|
TREVI THERAPEUTICS INC | $8.0 million |
|
URGN
|
UROGEN PHARMA LTD | $8.0 million |
|
IMCR
|
IMMUNOCORE HOLDINGS ADR PLC | $7.9 million |
|
XTSLA
|
BLK CSH FND TREASURY SL AGENCY | $7.8 million |
|
BHVN
|
BIOHAVEN LTD | $7.6 million |
|
GRFS
|
GRIFOLS ADR REPRESENTING ONE NON-V | $7.6 million |
|
NUVB
|
NUVATION BIO INC CLASS A | $7.5 million |
|
RAPP
|
RAPPORT THERAPEUTICS INC | $7.4 million |
|
KALV
|
KALVISTA PHARMACEUTICALS INC | $7.3 million |
|
CMPS
|
COMPASS PATHWAYS ADR PLC | $7.2 million |
|
GHRS
|
GH RESEARCH PLC | $7.2 million |
|
LKFT
|
LAKEFRONT BIOTHERAPEUTICS ADR NV | $7.2 million |
|
WVE
|
WAVE LIFE SCIENCES LTD | $7.1 million |
|
SION
|
SIONNA THERAPEUTICS INC | $6.9 million |
|
ABCL
|
ABCELLERA BIOLOGICS INC | $6.9 million |
|
CDNA
|
CAREDX INC | $6.9 million |
|
VIR
|
VIR BIOTECHNOLOGY INC | $6.8 million |
|
MESO
|
MESOBLAST ADR REPRESENTING LTD | $6.6 million |
|
OLMA
|
OLEMA PHARMACEUTICALS INC | $6.5 million |
|
MNKD
|
MANNKIND CORP | $6.4 million |
|
STVN
|
STEVANATO GROUP | $6.3 million |
|
GLUE
|
MONTE ROSA THERAPEUTICS INC | $6.0 million |
|
MBX
|
MBX BIOSCIENCES INC | $6.0 million |
|
MAZE
|
MAZE THERAPEUTICS INC | $5.6 million |
|
TBPH
|
THERAVANCE BIOPHARMA INC | $5.6 million |
|
PHVS
|
PHARVARIS N V NV | $5.5 million |
|
KURA
|
KURA ONCOLOGY INC | $5.5 million |
|
GERN
|
GERON CORP | $5.4 million |
|
CRVS
|
CORVUS PHARMACEUTICALS INC | $5.4 million |
|
BCAX
|
BICARA THERAPEUTICS INC | $5.4 million |
|
JANX
|
JANUX THERAPEUTICS INC | $5.3 million |
|
SEPN
|
SEPTERNA INC | $5.2 million |
|
XNCR
|
XENCOR INC | $5.2 million |
|
AVBP
|
ARRIVENT BIOPHARMA INC | $5.2 million |
|
ANNX
|
ANNEXON INC | $5.1 million |
|
ABUS
|
ARBUTUS BIOPHARMA CORP | $4.6 million |
|
CTMX
|
CYTOMX THERAPEUTICS INC | $4.6 million |
|
PGEN
|
PRECIGEN INC | $4.5 million |
|
CGEM
|
CULLINAN THERAPEUTICS INC | $4.5 million |
|
MGTX
|
MEIRAGTX HOLDINGS PLC | $4.5 million |
|
ABSI
|
ABSCI CORP | $4.4 million |
|
ANRO
|
ALTO NEUROSCIENCE INC | $4.3 million |
|
IRWD
|
IRONWOOD PHARMA INC CLASS A | $4.2 million |
|
ZVRA
|
ZEVRA THERAPEUTICS INC | $4.2 million |
|
CSTL
|
CASTLE BIOSCIENCES INC | $4.1 million |
|
PHAT
|
PHATHOM PHARMACEUTICALS INC | $4.0 million |
|
SANA
|
SANA BIOTECHNOLOGY INC | $3.7 million |
|
RIGL
|
RIGEL PHARMACEUTICALS INC | $3.7 million |
|
USD
|
USD CASH | $3.6 million |
|
SVRA
|
SAVARA INC | $3.6 million |
|
5CV.DE
|
CUREVAC NV | $3.6 million |
|
SLDB
|
SOLID BIOSCIENCES INC | $3.6 million |
|
BIOA
|
BIOAGE LABS INC | $3.4 million |
|
ACRS
|
ACLARIS THERAPEUTICS INC | $3.4 million |
|
ORIC
|
ORIC PHARMACEUTICALS INC | $3.3 million |
|
ARVN
|
ARVINAS INC | $3.3 million |
|
OPK
|
OPKO HEALTH INC | $3.3 million |
|
SPRY
|
ARS PHARMACEUTICALS INC | $3.3 million |
|
PSNL
|
PERSONALIS INC | $3.2 million |
|
MRVI
|
MARAVAI LIFESCIENCES HOLDINGS INC | $3.2 million |
|
ALLO
|
ALLOGENE THERAPEUTICS INC | $3.1 million |
|
ZBIO
|
ZENAS BIOPHARMA INC | $3.1 million |
|
CADL
|
CANDEL THERAPEUTICS INC | $3.1 million |
|
CTKB
|
CYTEK BIOSCIENCES INC | $3.1 million |
|
EBS
|
EMERGENT BIOSOLUTIONS INC | $3.0 million |
|
PRTA
|
PROTHENA PLC | $2.9 million |
|
BBOT
|
BRIDGEBIO ONCOLOGY THERAPEUTICS IN | $2.8 million |
|
FDMT
|
4D MOLECULAR THERAPEUTICS INC | $2.8 million |
|
ENTA
|
ENANTA PHARMACEUTICALS INC | $2.8 million |
|
LAB
|
STANDARD BIOTOOLS INC | $2.7 million |
|
ALVO
|
ALVOTECH SA | $2.7 million |
|
REPL
|
REPLIMUNE GROUP INC | $2.6 million |
|
CTNM
|
CONTINEUM THERAPEUTICS INC CLASS A | $2.5 million |
|
ALT
|
ALTIMMUNE INC | $2.5 million |
|
FULC
|
FULCRUM THERAPEUTICS INC | $2.5 million |
|
DSGN
|
DESIGN THERAPEUTICS INC | $2.5 million |
|
NGNE
|
NEUROGENE INC | $2.4 million |
|
CATX
|
PERSPECTIVE THERAPEUTICS INC | $2.4 million |
|
AURA
|
AURA BIOSCIENCES INC | $2.4 million |
|
VNDA
|
VANDA PHARMACEUTICALS INC | $2.3 million |
|
MYGN
|
MYRIAD GENETICS INC | $2.3 million |
|
DNA
|
GINKGO BIOWORKS HOLDINGS INC CLASS | $2.3 million |
|
CABA
|
CABALETTA BIO INC | $2.3 million |
|
PACB
|
PACIFIC BIOSCIENCES OF CALIFORNIA | $2.3 million |
|
FLGT
|
FULGENT GENETICS INC | $2.3 million |
|
RCKT
|
ROCKET PHARMACEUTICALS INC | $2.2 million |
|
AUTL
|
AUTOLUS THERAPEUTICS ADR PLC | $2.2 million |
|
KYTX
|
KYVERNA THERAPEUTICS INC | $2.1 million |
|
LXEO
|
LEXEO THERAPEUTICS INC | $2.0 million |
|
ADCT
|
ADC THERAPEUTICS SA | $2.0 million |
|
OABI
|
OMNIAB INC | $2.0 million |
|
TECX
|
TECTONIC THERAPEUTIC INC | $2.0 million |
|
CYBN
|
CYBIN INC | $2.0 million |
|
LCTX
|
LINEAGE CELL THERAPEUTICS INC | $1.9 million |
|
RGNX
|
REGENXBIO INC | $1.9 million |
|
AVIR
|
ATEA PHARMACEUTICALS INC | $1.8 million |
|
IMRX
|
IMMUNEERING CORP CLASS A | $1.8 million |
|
PRME
|
PRIME MEDICINE INC | $1.8 million |
|
CCCC
|
C4 THERAPEUTICS INC | $1.8 million |
|
EDIT
|
EDITAS MEDICINE INC | $1.7 million |
|
AVXL
|
ANAVEX LIFE SCIENCES CORP | $1.7 million |
|
UPB
|
UPSTREAM BIO INC | $1.7 million |
|
CDXS
|
CODEXIS INC | $1.6 million |
|
KROS
|
KEROS THERAPEUTICS INC | $1.3 million |
|
LENZ
|
LENZ THERAPEUTICS INC | $1.3 million |
|
ACIU
|
AC IMMUNE SA | $1.3 million |
|
ARCT
|
ARCTURUS THERAPEUTICS HOLDINGS INC | $1.3 million |
|
SGMT
|
SAGIMET BIOSCIENCES INC SERIES A | $1.3 million |
|
CRBU
|
CARIBOU BIOSCIENCES INC | $1.2 million |
|
LRMR
|
LARIMAR THERAPEUTICS INC | $1.2 million |
|
CLLS
|
CELLECTIS ADR REPRESENTING SA | $1.2 million |
|
VYGR
|
VOYAGER THERAPEUTICS INC | $1.2 million |
|
HUMA
|
HUMACYTE INC | $1.2 million |
|
QSI
|
QUANTUM SI INC CLASS A | $1.1 million |
|
BCYC
|
BICYCLE THERAPEUTICS ADR PLC | $1.0 million |
|
BDTX
|
BLACK DIAMOND THERAPEUTICS INC | $1.0 million |
|
SLN
|
SILENCE THERAPEUTICS ADR REPRESENT | $967819 |
|
TNYA
|
TENAYA THERAPEUTICS INC | $914559 |
|
TRDA
|
ENTRADA THERAPEUTICS INC | $899553 |
|
NBP
|
NOVABRIDGE BIOSCIENCES ADR | $877173 |
|
LYEL
|
LYELL IMMUNOPHARMA INC | $849179 |
|
SGAFT
|
CASH COLLATERAL USD SGAFT | $800000 |
|
FHTX
|
FOGHORN THERAPEUTICS INC | $777592 |
|
PYXS
|
PYXIS ONCOLOGY INC | $696920 |
|
QTRX
|
QUANTERIX CORP | $691884 |
|
NMRA
|
NEUMORA THERAPEUTICS INC | $681112 |
|
PEPG
|
PEPGEN INC | $602775 |
|
MENS
|
JYONG BIOTECH LTD | $435638 |
|
AARD
|
AARDVARK THERAPEUTICS INC | $379311 |
|
IMMP
|
IMMUTEP ADS REPRESENTING LTD | $359232 |
|
AKE
|
AKERO THERAPEUTICS CVR | $340529 |
|
GOSS
|
GOSSAMER BIO INC | $291057 |
|
TKNO
|
ALPHA TEKNOVA INC | $286674 |
|
TRAXV
|
FIRST TRACKS BIOTHERAPEUTICS INC | $181945 |
|
ADRO
|
CHINOOK THERAPEUTICS INC | $54563 |
|
None
|
ARCELLX INC CVR | $23506 |
|
None
|
CARTESIAN THERAPEUTICS INC | $1948 |
|
None
|
FUSION PHARMACEUTICALS INC CVR | $1034 |
|
CRGX
|
CARGO THERAPEUTICS INC | $1 |
|
None
|
AKOUOS CVRS Prvt | $1 |
|
THRD
|
THIRD HARMONIC BIO INC | $1 |
|
None
|
OMNIAB INC $15.00 VESTING Prvt | $0 |
|
None
|
OMNIAB INC $12.50 VESTING Prvt | $0 |
|
RTYM6
|
RUSSELL 2000 EMINI CME JUN 26 | $0 |
|
IXCM6
|
E-MINI HEALTH CARE SECTOR JUN 26 | $0 |
|
IXCH6
|
E-MINI HEALTH CARE SECTOR MAR 26 | $0 |
Recent Changes - iShares Biotechnology ETF
| Date | Ticker | Name | Change (Shares) |
|---|---|---|---|
| 2026-05-19 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-05-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-05-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-05-13 |
APLS
|
Apellis Pharmaceuticals Inc | -648,908 |
| 2026-05-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-05-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-05-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-05-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-05-06 |
TERN
|
TERNS PHARMACEUTICALS INC | -704,986 |
| 2026-05-04 |
ASND
|
ASCENDIS PHARMA | 336,632 |
| 2026-05-04 |
ASND
|
ASCENDIS PHARMA | -338,060 |
| 2026-05-01 |
ASND
|
ASCENDIS PHARMA | -338,060 |
| 2026-05-01 |
ASND
|
ASCENDIS PHARMA | 338,060 |
| 2026-04-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-04-30 |
ASND
|
ASCENDIS PHARMA | 338,060 |
| 2026-04-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-04-29 |
ASND
|
ASCENDIS PHARMA | -336,774 |
| 2026-04-28 |
ACLX
|
Arcellx Inc | -335,814 |
| 2026-04-28 |
ASND
|
ASCENDIS PHARMA | 336,774 |
| 2026-04-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-04-28 |
FOLD
|
Amicus Therapeutics Inc | -2.3 million |
| 2026-04-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-04-24 |
ASND
|
ASCENDIS PHARMA | -342,084 |
| 2026-04-23 |
ASND
|
ASCENDIS PHARMA | 342,084 |
| 2026-04-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-04-23 |
DAWN
|
Day One Biopharmaceuticals Inc | -580,579 |
| 2026-04-21 |
ASND
|
ASCENDIS PHARMA | 341,007 |
| 2026-04-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-04-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-04-20 |
TRAXV
|
FIRST TRACKS BIOTHERAPEUTICS INC | 192,736 |
| 2026-04-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-04-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-04-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-04-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-04-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-04-10 |
SGAFT
|
CASH COLLATERAL USD SGAFT | -20,000 |
| 2026-04-10 |
SGAFT
|
CASH COLLATERAL USD SGAFT | 257,000 |
| 2026-04-10 |
USD
|
USD CASH | -1.7 million |
| 2026-04-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-04-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-04-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-03-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-03-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-11 |
THRD
|
THIRD HARMONIC BIO INC | -134,478 |
| 2026-03-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-03-05 |
VTYX
|
Ventyx Biosciences Inc | -473,207 |
| 2026-03-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-03 |
RAPT
|
RAPT Therapeutics Inc Ordinary Shares | -133,793 |
| 2026-03-03 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-02 |
RNA
|
Atrium Therapeutics Inc | -101,552 |
| 2026-03-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-03-02 |
RNAGBP
|
Avidity Biosciences Inc Ordinary Shares | -1.0 million |
| 2026-02-27 |
RNA
|
ATRIUM THERAPEUTICS INC | 101,552 |
| 2026-02-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-02-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-10 |
DVAX
|
DYNAVAX TECHNOLOGIES CORP | -845,239 |
| 2026-02-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-02-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-02-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-29 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -698,378 |
| 2026-01-29 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-29 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-29 |
DFTX
|
DEFINIUM THERAPEUTICS INC | 700,502 |
| 2026-01-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-28 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-28 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 698,378 |
| 2026-01-28 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -698,378 |
| 2026-01-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-28 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-27 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-27 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 701,918 |
| 2026-01-27 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-27 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -703,334 |
| 2026-01-26 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-26 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 703,334 |
| 2026-01-26 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-26 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -699,794 |
| 2026-01-23 |
MNMD
|
DEFINIUM THERAPEUTICS INC | -699,086 |
| 2026-01-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-23 |
ATAI
|
AtaiBeckley Inc | 2.0 million |
| 2026-01-23 |
ATAI
|
ATAIBECKLEY INC | -2.0 million |
| 2026-01-23 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | 699,794 |
| 2026-01-22 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 699,086 |
| 2026-01-22 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-22 |
ATAI
|
ATAIBECKLEY INC | 2.0 million |
| 2026-01-22 |
ATXS
|
Astria Therapeutics Inc | -369,763 |
| 2026-01-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-22 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | -701,210 |
| 2026-01-21 |
MNMD
|
DEFINIUM THERAPEUTICS INC | -699,794 |
| 2026-01-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-21 |
ATAI
|
ATAIBECKLEY NV | -2.0 million |
| 2026-01-21 |
ATAI
|
AtaiBeckley Inc | 2.0 million |
| 2026-01-21 |
DFTX
|
Definium Therapeutics Inc Ordinary Shares | 701,210 |
| 2026-01-16 |
MNMD
|
DEFINIUM THERAPEUTICS INC | 707,582 |
| 2026-01-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-16 |
ATAI
|
ATAIBECKLEY NV | 2.0 million |
| 2026-01-16 |
DFTX
|
Mind Medicine Inc Ordinary Shares | -707,582 |
| 2026-01-16 |
ATAI
|
AtaiBeckley Inc | -2.0 million |
| 2026-01-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2026-01-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-07 |
CVAC
|
CUREVAC NV | -953,194 |
| 2026-01-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2026-01-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-29 |
STRO
|
Sutro Biopharma Inc | -139 |
| 2025-12-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-24 |
ARTV
|
Artiva Biotherapeutics Inc | -14,185 |
| 2025-12-24 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -805 |
| 2025-12-24 |
FATE
|
Fate Therapeutics Inc | -22,037 |
| 2025-12-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-16 |
MRUS
|
Merus NV | -6,411 |
| 2025-12-10 |
AKRO
|
Akero Therapeutics Inc | -515,954 |
| 2025-12-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-12-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-03 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-12-01 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-11-19 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-11-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-12 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-11-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-11-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-07 |
SGAFT
|
CASH COLLATERAL USD SGAFT | 288,000 |
| 2025-11-07 |
SGAFT
|
CASH COLLATERAL USD SGAFT | -288,000 |
| 2025-11-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-11-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-11-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-04 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-11-03 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-11-03 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-31 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-10-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-10-30 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-29 |
ETNB
|
89BIO INC | -882,111 |
| 2025-10-28 |
TRML
|
TOURMALINE BIO INC | -100,019 |
| 2025-10-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-10-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-10-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-10-22 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-10-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-20 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-10-17 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-10-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-16 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-10-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-08 |
VRNA
|
VERONA PHARMA ADR PLC | -326,177 |
| 2025-10-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-10-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |